Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort
- PMID: 22554417
- PMCID: PMC4786375
- DOI: 10.1016/j.jcf.2012.04.003
Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort
Abstract
Background: Risk factors for initial Pseudomonas aeruginosa (Pa) acquisition, particularly environmental exposures, are poorly understood. We aimed to identify such risk factors in order to inform prevention strategies and identify high-risk populations.
Methods: The study cohort included all participants in the U.S. EPIC Observational Study who had no prior Pa-positive respiratory cultures (N=889). Cox proportional hazard models were used to test the effects of factors on age at first Pa-positive respiratory culture.
Results: Cystic fibrosis (CF) genotype functional class had an important effect on age at initial Pa acquisition (hazard ratio (HR) comparing minimal to residual CFTR function 2.87 (95% CI 1.88, 4.39)). None of the modifiable risk factors evaluated, including cigarette smoke, hot tub use, breastfeeding, or daycare, was associated with age at Pa acquisition. Similarly, newborn screening was not associated with age at Pa acquisition (HR 0.85, 95% CI 0.66, 1.09). Key associations were validated in a CF Foundation National Patient Registry replication cohort.
Conclusions: Given the ubiquitous presence of Pa in the environment, it may be that many imposed lifestyle changes will have less impact on age at initial Pa acquisition than genetic determinants.
Trial registration: ClinicalTrials.gov NCT00676169.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.Pediatr Pulmonol. 2010 Sep;45(9):934-44. doi: 10.1002/ppul.21279. Pediatr Pulmonol. 2010. PMID: 20597081
-
Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.Epidemiol Infect. 2016 Apr;144(5):1075-83. doi: 10.1017/S0950268815002411. Epub 2015 Oct 9. Epidemiol Infect. 2016. PMID: 26449886
-
Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.Respir Res. 2010 Oct 8;11(1):140. doi: 10.1186/1465-9921-11-140. Respir Res. 2010. PMID: 20932301 Free PMC article.
-
Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis.J Cyst Fibros. 2018 May;17(3):341-347. doi: 10.1016/j.jcf.2017.10.008. Epub 2017 Oct 28. J Cyst Fibros. 2018. PMID: 29110966 Free PMC article.
-
CFTR and pseudomonas infections in cystic fibrosis.Front Biosci. 2001 Aug 1;6:D890-7. doi: 10.2741/tatterso. Front Biosci. 2001. PMID: 11487480 Review.
Cited by
-
The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study.Lancet Respir Med. 2013 Apr;1(2):121-8. doi: 10.1016/S2213-2600(13)70002-X. Epub 2013 Jan 30. Lancet Respir Med. 2013. PMID: 24429092 Free PMC article.
-
Impact of intrinsic and extrinsic risk factors on early-onset lung disease in cystic fibrosis.Pediatr Pulmonol. 2023 Nov;58(11):3071-3082. doi: 10.1002/ppul.26625. Epub 2023 Aug 4. Pediatr Pulmonol. 2023. PMID: 37539852 Free PMC article.
-
Exploring the 175-year history of spirometry and the vital lessons it can teach us today.Eur Respir Rev. 2021 Oct 5;30(162):210081. doi: 10.1183/16000617.0081-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34615699 Free PMC article. Review.
-
Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.J Clin Microbiol. 2015 Jun;53(6):1898-907. doi: 10.1128/JCM.00368-15. Epub 2015 Apr 8. J Clin Microbiol. 2015. PMID: 25854483 Free PMC article.
-
Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care.Int J Neonatal Screen. 2020 Apr 14;6(2):34. doi: 10.3390/ijns6020034. eCollection 2020 Jun. Int J Neonatal Screen. 2020. PMID: 33073029 Free PMC article.
References
-
- Rosenfeld M, Emerson J, Joubran K, Morgan W, Gibson R, for the EPIC Study Group Risk factors for early pseudomonas acquisition in a large cohort of young US CF patients. Pediatr Pulmonol. 2009;S32:373.
-
- Cystic Fibrosis Foundation. National Patient Registry 2010 Annual Data Report. Bethesda, Maryland: 2011.
-
- Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32(4):277–87. - PubMed
-
- Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91–100. - PubMed
-
- Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr. 2007;151(2):134–9 [9 e1]. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical